Board-certified subspecialists in the Division of Pediatric Allergy, Asthma and Immunology specialize in the diagnosis and treatment of children with allergic and immunologic diseases. Allergic ...
Please provide your email address to receive an email when new articles are posted on . Children with growth hormone deficiency assigned long-acting recombinant GH therapy experienced an increase in ...
The product, lonapegsomatropin, is a sustained-release formulation and could replace daily injections. The FDA recently approved the first once-weekly somatropin injection for pediatric patients 1 ...
The section of Pediatric Orthopaedics provides comprehensive care to patients from birth through 18 years of age. We provide a wide range of services, including the treatment of scoliosis and other ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved the first once-weekly formulation of somatropin for children with growth hormone deficiency, ...
Health Canada approves Pr AJOVY® (fremanezumab solution for subcutaneous injection) for the prevention of episodic migraine (fewer than 15 migraine days per month) in pediatric patients aged 6 to 17 ...
The Saint Louis University Division of Pediatric Dermatology is a nationally recognized center of expertise, providing tertiary medical, surgical and investigative dermatology services for children ...
Updated IDSA/PIDS guidelines for 2026 provide recommendations for managing CAP-associated parapneumonic effusion in children.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results